Investors considering a purchase of BioTime Inc (BTX - Get Report) shares, but cautious about paying the going market price of $2.82/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $2 strike, which has a bid at the time of this writing of 15 cents. Collecting that bid as the premium represents a 7.5% return against the $2 commitment, or a 12% annualized rate of return (at Stock Options Channel we call this the YieldBoost).Selling a put does not give an investor access to BTX's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $2 strike if doing so produced a better outcome than selling at the going market price. ( Do options carry counterparty risk? This and six other common options myths debunked). So unless BioTime Inc sees its shares decline 29.8% and the contract is exercised (resulting in a cost basis of $1.85 per share before broker commissions, subtracting the 15 cents from $2), the only upside to the put seller is from collecting that premium for the 12% annualized rate of return. Below is a chart showing the trailing twelve month trading history for BioTime Inc, and highlighting in green where the $2 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the September put at the $2 strike for the 12% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for BioTime Inc (considering the last 252 trading day closing values as well as today's price of $2.82) to be 48%. For other put options contract ideas at the various different available expirations, visit the BTX Stock Options page of StockOptionsChannel.com.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Ear to the Ground on UTX-Raytheon: What Needs to Happen for the Deal to Close
Shareholders are skittish about this deal, one analyst said. See why they shouldn't be.
AbbVie Rebounds as Market Warms to Allergan Deal, Botox Potential
AbbVie's deal for Allergan will give it a new revenue stream in Botox, helping offset potential lower revenue from arthritis drug Humira, which is losing patent protection.
Care.com Shares Slump After Chief Financial Officer Resigns
Care.com's finance chief resigns a few months after a Wall Street Journal report that many day-care centers listed on the company's site were unlicensed.
Dow Ends Down on Mixed Trade Messages From Mnuchin, Trump
Stocks end mixed after Treasury Secretary Steven Mnuchin says the U.S. and China were close to reaching a trade agreement, while President Trump hints that he wants to make a trade deal with Beijing but is happy where things are now.